A new twist to menopausal hormone replacement dilemma
Sept. 12, 2017
| Sabin Russell / Fred Hutch News Service
New follow-up research to a landmark study on menopausal hormone replacement therapy has found that women assigned to those drugs on the study had no higher risk of death than women who took a placebo.
A new algorithm created by Dr. Philip Bradley and colleagues could aid the development of tools to decode T-cell receptor sequences and, ultimately, improve the diagnosis and treatment of cancers, reported this week in Nature.
Dr. Katherine A. Guthrie, a biostatistician in the Public Health Sciences Division at Fred Hutch, is co-leading a $7 million grant that includes a multicenter clinical trial that will compare popular treatments for menopause-related vaginal symptoms ranging from dryness and atrophy (thinning and shrinking of the tissues) to itching, irritation and painful intercourse.